– Full professor of Obstetrics and Gynecology and Chairman of the Resident Program in Obstetrics and Gynecology at the University of Florence and Chairman of the Division Ob&Gyn and of the Department of Maternal and Infancy at the University Hospital Careggi in Florence, Italy.

– He was previously Professor at the Universities of Modena, Pisa, Udine e Siena and Visiting Professor at the University of Toronto, Toronto (Canada), University of Sydney, Sydney (Australia) and Capital University, Peking (China).

– Fellow ad Eundem of the Royal College of Obstetricians and Gynaecologists (FRCOG).

– Awarded by the National Academy Lincei, Endocrine Society (USA) and by the Society for Gynecologic Investigation (USA).

– Past President of the Society for Endometriosis and Uterine Disorders (SEUD) and past President of the Society for Gynecological Investigation (SGI); member of the Executive Committee of the International Federation of Gynecology and Obstetrics (FIGO), European Board and College Obstetrics and Gynecology (EBCOG) , International Society Gynecological Endocrinology (ISGE) and Chair of a Special Interest Group ESHRE..

– Author and co-Author 970 peer reviewed publications in International Scientific Journals (Hirsch Index=96; 42853 citations – Google Scholar – IF. 2990,15 )

– Author and co-Author of 29 books.

– Editore-in-Chief of Human Reproduction Update (2013-2018) and Journal of Endometriosis (2009-2012);
– Editor Emeritus of Human Reproduction Update;
– Editor di RBMOnline, Associate Editor di Faculty of 1000 Medicine website (Section Head in Reproductive Endocrinology), of Reproductive Sciences and Journal of Endocrinological Investigation (1992-2009) and Editorial Board member of Journal Clinical Endocrinology and Metabolism, European Journal of Endocrinology, Journal of Endocrinologial Investigation, Placenta, Frontiers in Endocrinology, Fertility & Sterility Sciences.

– Invited speaker at more than 200 International Meetings and President of 18 International Meetings.

www.drfcarmona.com/

He has been member of the University of Barcelona’s Department of Obstetrics and Gynaecology as Professor from 2006.

His main areas of interest are endometriosis and benign diseases including pelvic floor pathology. He has published more than 100 scientific articles in the most important medical journals both general (as The Lancet and JAMA) and of his speciality (including AJOG, Hum Rep, Fertil Steril and many others). He is also author of more than 20 book chapters both in English and in Spanish. Dr. Carmona acts as invited referee for several important medical journals including Fertility and Sterility and Human Reproduction. He is also member of the Editorial Board of Gynecological Surgery, Journal of Endometriosis and Pelvic Pain Disorders and Medicina Clínica.

He is member of a number of different medical associations including ESGE (he was member of the Board Committee of this society from 2006 to 2010), AAGL (current member of the Advisory Board and past member of the Board of Trustees: 2012-2014), SIAEGI (current member of the Executive Committee), EEL (past member of the Executive Board), SEUD (founding member and Executive Board Member), WES (Ambassador) and the Spanish Gynecologic Endoscopic Society (member of its Grupo de Expertos en Endoscopia). From the late 1990 he has organized advanced endoscopic courses and workshops on minimally invasive surgery and he was the President of the 19th Congress of the ESGE and President of the 10th International Meeting of the AAGL.

MD PhD FRCSC FACOG CCRP

Dr Ayman Al-Hendy is currently a Professor (Tenure) and Vice Chair (Research), Department of Obstetrics and Gynecology, Advisor to Dean of Medicine, Pritzker School of Medicine, University of Chicago (UC). Dr. Al-Hendy is a Gynecologist and minimally-invasive Surgeon at UC Medical Center, Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency.

Dr. Al-Hendy graduated from Banha Faculty of Medicine, Zagazig University, Banha, Egypt in 1986. After 1 year of internship at Banha University Hospital, he headed to Finland to earn his PhD in Molecular Medicine from University of Turku, Turku, Finland. He then gained additional postdoctoral training in gene/cell therapy and clinical molecular genetics at McMaster University and McGill University in Canada, before completing clinical residency training in Obstetrics and Gynecology at University of Saskatchewan and fellowship training in laparoscopic surgery at Toronto University, both in Canada. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. In United States of America, Dr. Al-Hendy held various faculty positions at University of Texas Medical Branch, Galveston, Texas, Meharry Medical College/Vanderbilt University, Nashville, Tennessee, and Medical College of Georgia, Augusta, Georgia, before moving to Chicago, Illinois.

Dr. Al-Hendy utilizes the methods of basic, translational, clinical and community research to address important medical diseases. Dr. Al-Hendy medical research interests focus on developing novel therapies including gene and stem cell therapy for Premature Ovarian insufficiency, Endometriosis, and particularly Uterine Fibroids. He has championed the use of specific natural fertility-friendly non-hormonal compounds such as green tea extracts (Epigalcatchin Gallate, EGCG) and vitamin D for prevention and treatment of uterine fibroids. He was first (2010) to introduce hypovitaminosis D as a risk factor to development of uterine fibroids and a contributing reason of why they are much more prevalent in women of color. An observation that has been confirmed subsequently by numerous publications globally.

Dr. Al-Hendy also pioneered (2009) the concept of enhancing ovarian folliculogenesis via direct intra-ovarian injection of appropriate augmenting biologics. After ample preclinical work on utilizing human bone marrow mesenchymal stem cells or its exosomes (naïve or enhanced) to treat representative animal models, Dr. Al-Hendy has started clinical trials to translate such innovative approach to women suffering from premature ovarian insufficiency as well as other ovarian causes of infertility.

In 2010, Dr. Al-Hendy was awarded the American Society of Reproductive Medicine’s (ASRM) 2010 Ira and Ester Rosenwaks Award for his significant contribution to the field of translational Reproductive Biology. In 2014 he received the alpha Omega alpha clinician scientist of the year award by the Medical Honor Society and in 2015 the President Achievement Award as well as Rogerio A. Lobo Award from the Society of reproductive Investigations (SRI). Dr. Al-Hendy research has been continuously funded by various agencies since 2002 including NIH (NICHD, NIEHS, NIMHD, ODS, OD, NCRR), USDA, and other national and international organizations. He has served as Chair of the NIH Integrative Clinical Endocrinology and Reproduction (ICER) IRG 2013-2015 and also serves on numerous other committees with organizations such NIH, ASRM, SRI and as Co-Editor-in-Chief of The SRI Journal, Reproductive Sciences as well as on several editorial boards of high impact journals. Dr. Al-Hendy has been elected as SRI 71st President. He has published more than 260 peer reviewed medical articles in high tier peer reviewed scientific journals with more than 11,000 citations in the understudied area of non-malignant (benign) gynecology (H-index 58), above 400 presentations in national and international meetings, and has edited 5 medical books.

Bart CJM Fauser, MD, PhD, FRCOG, is a Professor Em. of Reproductive Medicine, Gynecologist, former Head of the Department for Reproductive Medicine and Gynecology and former Chair of the Division of Woman & Baby at the University of Utrecht and the University Medical Center Utrecht, The Netherlands.

He is the scientific director of the International Federation of Fertility Societies (IFFS), consultant and advisory board member of many companies. In addition, he is a Fellow ad Eundum of the Royal College of Obstetrics and Gynaecology (RCOG), Honorary member of European Society of Human Reproduction and Embryology (ESHRE), Honorary member of the Middle East Fertility Society (MEFS), international member of the US National Academy of Medicine (NAM), member of the Academia Europea, Night in the order of the Netherlands Lion, past member of the board of the Dutch Medical Research Counsel (ZonMW), past chair of the World Health Organization (WHO) steering committee for infertility guidelines, past Editor-in-Chief of Reproductive Biomedicine Online (RBMO), and past Editor-in-Chief of Human Reproduction Update.

He previously held posts as a Fulbright scholar at the University of California, San Diego; and visiting professorships at Stanford University School of Medicine (California, USA), Free University of Brussels (Belgium), University of Siena (Italy), University of Southampton (UK), and the University of Adelaide (Australia).

His major research interests include the pathophysiology of human ovarian function (especially PCOS, POI, and ovarian aging), ovarian stimulation, IVF and women’s health (including contraception, and healthy aging). Professor Fauser published over 500 peer-reviewed scientific articles, Hirsch factor 119 (SCOPUS), and he is the No 1 in the 2024 Global Top Scientist list in the field of Obstetrics and Gynecology (Stanford/Elsevier Top 2% Scientists List 2024 – Top 2% Scientists). He has acted as the editor of multiple textbooks, wrote chapters for all leading textbooks in Reproductive Medicine, lectured all around the world and his work has been widely covered in the national and international news media.

M.D., Ph.D.

Kaori Koga is the Professor and Chair of the Department of Obstetrics and Gynecology, Reproductive Medicine, Graduate School of Medicine, Chiba University, Japan.

She received her M.D. degree from Chiba University in 1996, and her Ph.D. degree from the University of Tokyo in 2003.  She then worked as a post-doctoral fellow in the Uterine Biology Group (Lois Salamonsen’s laboratory) at the Prince Henry’s Institute, Australia, and in the Reproductive Immunology Unit (Gil Mor’s laboratory) at Yale University.

Her expertise is in the management of endometriosis, including MIS and ART.  She is the author or co-author of more than 200 scientific articles published in peer-reviewed international journals.

Prof. Koga is a board member of the World Endometriosis Society and the Society of Endometriosis and Uterine Disorders, and a member of the European Society of Human Reproduction and Embryology, the American Society for Reproductive Immunology and the International Society for Immunology of Reproduction.

Ludwig Kiesel, MD PhD
Senior Professor, Department of Gynecology and Obstetrics at the University of Münster,Germany

Medical and research training and positions
• School of Medicine, University of Heidelberg, and Royal Free Hospital

Medical School, Univer¬sity of London, UK, (1975 – 1981)
• Medical thesis (M. D.), University of Heidelberg, (1977 – 1981)
• Postdoctoral fellowship at the National Institutes of Health in

Bethesda, USA (1981 – 1982)
• Residency and fellow at the Dept of OBGYN at the University of

Heidelberg (1983 -1991)
• Ph. D. thesis at the University of Heidelberg, (1991)
• Faculty member at the Dept of OBGYN at the University of Tübingen (1992 – 2000)
• Chairman at the Dept of OBGYN at the University of Münster (2000 – 2024)

Clinical and research interests
• Gynaecological endocrinology, Endometriosis, Menopause, Hormonal regulation of breast cancer

Professíonal board memberships
• Past President, German Society of Gynaecologic Endocrinology and

Reproductive Medicine (DGGEF) 2017-2024
• Past President, German Menopause Society (DMG) 2004-2010
• Past President, German Joint Societies of Reproduction (DVR) 2006-2009
• Past President, German Endometriosis Foundation (SEF) 2008-2012
• Board Member of the German Endometriosis Foundation (SEF) 2008-present
• Board Member of the World Endometriosis Society 2011-2017
• Board Member of the European Menopause and Andropause Society (EMAS) 2019 – 2021
• Editorial Board Member, Acta Obstetricia et Gynecologica Scandinavica (AGOS)
• Editorial Board Member, Gynecological Endocrinology (Journal of ISGE)
• Editorial Board Member, Gynecology and Pelvic Medicine
• Editorial Board Member, Journal of Endometriosis and Pelvic Pain

Disorders, Sage
• Editorial Board Member, Breast Care, Karger
• Editorial Board Member, Gynäkologische Endokrinologie, Springer
• Editorial Board Member Die Gynäkologie, Springer

Guideline Group
• Member of the PCOS guideline (DGE/DGGG)
• Coordinator of the German Contraception Guideline Group (DGGG)
• Member of the European Endometriosis Guideline Group (ESHRE)
• Member of the guideline on pelvic pain (DGGG)
• Member of the World Endometriosis Society Consensus Board (WES/WERF)

Dr. Olarik Musigavong, M.D., MSc. – Board
Member Biography

Dr. Olarik Musigavong is a distinguished reproductive medicine specialist and gynecologic endoscopist at Chaophya Abhaibhubejhr Hospital, Thailand. He earned his medical degree from Khon Kaen University (2005) and holds advanced qualifications in obstetrics and gynecology and reproductive medicine. His international training includes fellowships in Japan, an MBA from Mahidol University, and a Master’s in Biotechnology of Human Assisted Reproduction from the University of Valencia, Spain.

Currently serving as Head of Reproductive Endocrinology and Surgery Clinic, Dr. Musigavong has held prestigious leadership positions internationally. He chaired the American Society of Reproductive Medicine’s Complementary and Alternative Medicine Special Interest Group (2019-2020) and served as Director of Maternal and Infant Health Department at Thailand’s Ministry of Public Health (2023-2024). He has also been Deputy Ministry of Public Health Spokesperson and serves on the Medical Council of Thailand.

An internationally recognized speaker and educator, Dr. Musigavong delivers lectures at major medical conferences globally on reproductive surgery techniques, minimally invasive gynecologic procedures, and endoscopic innovations. He conducts innovative workshops for local and international healthcare providers on leveraging social media to increase health awareness and patient education, training professionals globally on digital health strategies and modern medical communication methods. His surgical education programs focus on advanced laparoscopic techniques and reproductive endocrinology.

As a board member of the International Society of Minimal Invasive and Virtual Surgery since 2023, Dr. Musigavong brings expertise in reproductive surgery, gynecologic endoscopy, and healthcare innovation. His research interests include AI in healthcare and health technology startups. He serves on the editorial board of Best Practice & Research: Clinical Obstetrics & Gynaecology and is an active member of multiple international medical societies.

SUMMARY CURRICULUM VITAE DR. PERE N. BARRI SOLDEVILA

• He was born in Barcelona in 1976
• Degree in Medicine at Universitat Autónoma de Barcelona in 2001
• Specialized in Gynecology and Obstetrics at Dexeus University Institute from 2001 to 2005.
• “Chef de Clinique” of gynecological surgery at Hôpital Bichat Claude Bernard (Paris, 2005-2006)
• EMBA on management in health care delivery at Harvard Business School (2015)
• Team Director of Humanitarian surgery expeditions to Africa, under the auspices of Fundación Dexeus Mujer
• Scientific societies:
  -Member of the “American Association of Gynecologic Laparoscopists” (AAGL) and Past Board Member (2018-2020)
  -Member of “European Society for Gynaecological Endoscopy” (ESGE)
  -Member of “Sociedad Española de Ginecología y Obstetricia” (SEGO) (member of its “Grupo de Expertos en Endoscopia”)
  -Member of “Societat Catalana d’Obstetrícia i Ginecologia” (SCOG)
  -Board Member of “Society of Endometriosis and Uterine Disorders” (SEUD)
• His mean fields of interest are deep endometriosis, reproductive surgery and pelvic floor pathology. He is involved in many surgical courses and international events as speaker and invited surgeon.
• Currently he is:
  -Director of Dexeus Mujer, Department of Obstetrics, Gynaecology and Human Reproduction of Hospital Universitario Quiron Dexeus.
  -Head of Dexeus Mujer Endometriosis Unit
  -Head of the FGM reconstruction program